Terms And Conditions
  1. Home
  2. Terms And Conditions
CSL Limited (ASX: CSL): Expects to deliver ~1...
By ACE Investors / 17 Jun 2025
Read More
EBR Systems Inc (ASX: EBR): Secured FDA appro...
By ACE Investors / 17 Jun 2025
Read More
Alterity Therapeutics Limited (ASX: ATH): Pro...
By ACE Investors / 17 Jun 2025
Read More
Merck & Co., Inc. (NYSE: MRK): Merck achieve...
By ACE Investors / 16 Jun 2025
Read More
Heron Therapeutics, Inc. (NASDAQ: HRTX): Achi...
By ACE Investors / 12 Jun 2025
Read More
Clinuvel Pharmaceuticals Limited (ASX: CUV): ...
By ACE Investors / 06 Jun 2025
Read More
MannKind Corp (NASDAQ: MNKD): Key Anticipated...
By ACE Investors / 05 Jun 2025
Read More
Healius Limited (ASX: HLS) – Industry funda...
By ACE Investors / 30 May 2025
Read More
INOVIQ Limited (ASX: IIQ): INOVIQ made signif...
By ACE Investors / 28 May 2025
Read More
EZZ Life Science Holdings Limited (ASX: EZZ):...
By ACE Investors / 26 May 2025
Read More
Paradigm Biopharmaceuticals Limited (ASX: PAR...
By ACE Investors / 26 May 2025
Read More
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN...
By ACE Investors / 26 May 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors